Blue Cross Blue Shield of Arizona contract update
We have reached an agreement with Blue Cross Blue Shield of Arizona.
RESTOR-1
A study is designed to evaluate the safety and efficacy of the AngioSafe Peripheral CTO Crossing System.
Principal Investigator: Georges Nseir, MD
https://clinicaltrials.gov/ct2/show/NCT04663867?term=restor+1&draw=2&rank=1
For questions, please call 480-728-9979.
Arrhythmia
Cardiac Genomics
Coronary Artery Disease
Heart Failure
Structural Heart
Brain Tumors - Neuro Oncology
COVID-19
Infectious Disease
Peripheral Artery Disease
Point of Care
Stroke
Trauma